MitoSense, Inc.
PrivateLast Round
Seed
Jan 26, 2024
Total Funding Raised
$3.5M
Company Overview
MitoSense, Inc. is a biotechnology company that develops treatments for neurodegenerative diseases using its proprietary Mitochondria Organelle Transplantation (MOT) technology to replenish mitochondria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoSense, Inc. Comparables
Compare MitoSense, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mitrix Bio | 84% | |
| PAEAN Biotechnology | 81% | |
| LUCA Science | 79% | |
MitoSense, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 26, 2024 | ||||
| Seed | Feb 8, 2023 |
MitoSense, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Caydan Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2024
Raised $2M in a Seed round.
MitoSense, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MitoSense, Inc.'s valuation, stock price, and market status.